Skip to main content
SpringerLink
Log in

Peri-RFA Care and Management of Complications

  • Chapter
  • First Online:
Radiofrequency Ablation for Small Hepatocellular Carcinoma

  • 709 Accesses

Abstract

Radiofrequency ablation (RFA) to treat primary and secondary hepatic malignancies have gained widespread acceptance over the past 10 years. RFA of hepatic tumors can now be performed with low morbidity and mortality rates. Clinicians performing RFA must recognize early and late complications of RFA so as to intervene with appropriate treatment early.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, Xu L, Lau WY. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol. 2013;39(8):865–72.

    Article  PubMed  Google Scholar 

  2. Xia F, Lai EC, Lau WY, Ma K, Li X, Bie P, Qian C. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma. Ann Surg Oncol. 2012;19(4):1284–91.

    Article  PubMed  Google Scholar 

  3. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232(3):381–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89(10):1206–22.

    Article  CAS  PubMed  Google Scholar 

  5. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN, Byun JY. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23(1):123–34.

    Article  PubMed  Google Scholar 

  6. Chen MH, Yan K, Yang W, Gao W, Dai Y, Wang YB, Zhang H, Huo L, Xing BC, Huang XF. Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications. Beijing Da Xue Xue Bao. 2005;37(3):292–6.

    PubMed  Google Scholar 

  7. Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, Canto A, Bernieri S, Bernardo G. Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver. Anticancer Res. 2007;27(4C):2911–6.

    PubMed  Google Scholar 

  8. Kasugai H, Osaki Y, Oka H, Kudo M, Seki T, Osaka Liver Cancer Study Group. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology. 2007;72 Suppl 1:72–5.

    Article  PubMed  Google Scholar 

  9. Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: an analysis of 16346 treated nodules in 13283 patients. Hepatol Res. 2012;42(11):1058–64.

    Article  PubMed  Google Scholar 

  10. Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, Takeda K. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200(3):658–64.

    Article  PubMed  Google Scholar 

  11. de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181(3):695–700.

    Article  PubMed  Google Scholar 

  12. Dodd 3rd GD, Napier D, Schoolfield JD, Hubbard L. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol. 2005;185:51–7.

    Article  PubMed  Google Scholar 

  13. Carrafiello G, Laganà D, Ianniello A, Dionigi G, Novario R, Recaldini C, Mangini M, Cuffari S, Fugazzola C. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol. 2007;51(6):550–4.

    Article  CAS  PubMed  Google Scholar 

  14. Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, Ohki T, Kondo Y, Goto T, Yoshida H, Omata M. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44(5):374–80.

    PubMed  Google Scholar 

  15. Chen MH, Dai Y, Yan K, Yang W, Gao W, Wu W, Liao SR, Hao CY. Intraperitoneal hemorrhage during and after percutaneous radiofrequency ablation of hepatic tumors: reasons and management. Chin Med J (Engl). 2005;118(20):1682–7.

    Google Scholar 

  16. Minami Y, Hayaishi S, Kudo M. Radiofrequency ablation for hepatic malignancies: is needle tract cauterization necessary for preventing iatrogenic bleeding? Dig Dis. 2013;31(5–6):480–4.

    Article  PubMed  Google Scholar 

  17. Birsen O, Aliyev S, Aksoy E, Taskin HE, Akyuz M, Karabulut K, Siperstein A, Berber E. A critical analysis of postoperative morbidity and mortality after laparoscopic radiofrequency ablation of liver tumors. Ann Surg Oncol. 2014;21(6):1834–40.

    Article  PubMed  Google Scholar 

  18. Ohnishi T, Yasuda I, Nishigaki Y, Hayashi H, Otsuji K, Mukai T, Enya M, Omar S, Soehendra N, Tomita E, Moriwaki H. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(8 Pt 2):e410–5.

    Article  PubMed  Google Scholar 

  19. Nakata Y, Haji S, Ishikawa H, Yasuda T, Nakai T, Takeyama Y, Shiozaki H. Two cases of hepatocellular carcinoma located adjacent to the Glisson’s capsule treated by laparoscopic radiofrequency ablation with intraductal chilled saline perfusion through an endoscopic nasobiliary drainage tube. Surg Laparosc Endosc Percutan Tech. 2010;20(6):e189–92.

    Article  PubMed  Google Scholar 

  20. Kurihara N, Kato H, Hirao K, Mizuno O, Ishida E, Okada H, Yamamoto K. Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma-Cooling effect by endoscopic nasobiliary drainage tube. Eur J Radiol. 2010;73:385–90.

    Article  PubMed  Google Scholar 

  21. Hirooka M, Kisaka Y, Uehara T, Ishida K, Kumagi T, Watanabe Y, Abe M, Matsuura B, Hiasa Y, Onji M. Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites. Dig Endosc. 2009;21(2):82–6.

    Article  PubMed  Google Scholar 

  22. Kim JS, Kim HS, Myung DS, Lee GH, Park KJ, Cho SB, Joo YE, Choi SK. A case of diaphragmatic hernia induced by radiofrequency ablation for hepatocellular carcinoma. Korean J Gastroenterol. 2013;62(3):174–8.

    Article  PubMed  Google Scholar 

  23. Nakamura T, Masuda K, Thethi RS, Sako H, Yoh T, Nakao T, Yoshimura N. Successful surgical rescue of delayed onset diaphragmatic hernia following radiofrequency ablation for hepatocellular carcinoma. Ulus Travma Acil Cerrahi Derg. 2014;20(4):295–9.

    Article  PubMed  Google Scholar 

  24. Han Y, Yu L, Hao YZ, Yang M, Liu S, Deng YB, He LF, Cai JQ, Chen MH. Percutaneous radiofrequency ablation with artificial hydrothorax for liver cancer in the hepatic dome. Zhonghua Zhong Liu Za Zhi. 2012;34(11):846–9.

    PubMed  Google Scholar 

  25. Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J, Barcelona Clínic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33(5):1124–9.

    Article  CAS  PubMed  Google Scholar 

  26. Jaskolka JD, Asch MR, Kachura JR, Ho CS, Ossip M, Wong F, Sherman M, Grant DR, Greig PD, Gallinger S. Needle tract seeding after radiofrequency ablation of hepatic tumors. J Vasc Interv Radiol. 2005;16(4):485–91.

    Article  PubMed  Google Scholar 

  27. Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005;92:856–8.

    Article  CAS  PubMed  Google Scholar 

  28. Perkins JD. Seeding risk following percutaneous approach to hepatocellular carcinoma. Liver Transpl. 2007;13(11):1603.

    Article  PubMed  Google Scholar 

  29. Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol. 2008;103:3057–62.

    Article  PubMed  Google Scholar 

  30. Latteri F, Sandonato L, Di Marco V, Parisi P, Cabibbo G, Lombardo G, Galia M, Midiri M, Latteri MA, Craxì A. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40(8):684–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chinese Academy of Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China

    Wan Yee Lau MD, DSc, FACS, FRCS, FRACS(Hon)

  2. Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China

    Eric C. H. Lai MBChB(CUHK), MRCS(Ed), FRACS

  3. Department of Surgery, Queen Elizabeth Hospital, Hong Kong SAR, China

    Stephanie H. Y. Lau MBChB(CUHK), MRCS(Ed), FRCS(Ed)

Authors
  1. Wan Yee Lau MD, DSc, FACS, FRCS, FRACS(Hon)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric C. H. Lai MBChB(CUHK), MRCS(Ed), FRACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie H. Y. Lau MBChB(CUHK), MRCS(Ed), FRCS(Ed)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wan Yee Lau MD, DSc, FACS, FRCS, FRACS(Hon) .

Editor information

Editors and Affiliations

  1. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Minshan Chen

  2. Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center Department of Hepatobiliary Surgery, Guangzhou, China

    Yaojun Zhang

  3. Prince of Wales Hospital, Chinese University of Hong Kong Prince of Wales Hospital, Hong Kong, China

    W.Y. Lau

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Lau, W.Y., Lai, E.C.H., Lau, S.H.Y. (2016). Peri-RFA Care and Management of Complications. In: Chen, M., Zhang, Y., Lau, W. (eds) Radiofrequency Ablation for Small Hepatocellular Carcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7258-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7258-7_7

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7257-0

  • Online ISBN: 978-94-017-7258-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation